IceCure Medical Takes Next Major Initiative As It Prepares To Accelerate The Commercialization Of ProSense In U.S. And Canada: Appoints VP Of Sales, North America
Portfolio Pulse from Happy Mohamed
IceCure Medical Ltd. (NASDAQ:ICCM) has appointed Shad Good as Vice President of Sales for North America. Good will be responsible for building a sales infrastructure in anticipation of a broader commercialization of the company's ProSense System in the U.S. and Canada. The company is awaiting the FDA's response to its regulatory filing for early-stage low risk breast cancer in patients who are at high risk for surgery.
August 28, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The appointment of Shad Good as VP of Sales for North America could potentially boost IceCure's sales and market presence in the region. The company's future performance is also dependent on the FDA's response to its regulatory filing.
Shad Good's appointment is a strategic move by IceCure to strengthen its sales infrastructure in North America. His experience in medical device sales could potentially drive the company's growth. However, the company's future performance is also contingent on the FDA's approval of its regulatory filing for early-stage low risk breast cancer treatment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100